These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 8171037

  • 1. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
    Fournié-Zaluski MC, Gonzalez W, Turcaud S, Pham I, Roques BP, Michel JB.
    Proc Natl Acad Sci U S A; 1994 Apr 26; 91(9):4072-6. PubMed ID: 8171037
    [Abstract] [Full Text] [Related]

  • 2. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Fournié-Zaluski MC, Coric P, Turcaud S, Rousselet N, Gonzalez W, Barbe B, Pham I, Jullian N, Michel JB, Roques BP.
    J Med Chem; 1994 Apr 15; 37(8):1070-83. PubMed ID: 8164250
    [Abstract] [Full Text] [Related]

  • 3. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1995 Jan 15; 272(1):343-51. PubMed ID: 7815350
    [Abstract] [Full Text] [Related]

  • 4. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I, Gonzalez W, el Amrani AI, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1993 Jun 15; 265(3):1339-47. PubMed ID: 8389863
    [Abstract] [Full Text] [Related]

  • 5. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension.
    French JF, Anderson BA, Downs TR, Dage RC.
    J Cardiovasc Pharmacol; 1995 Jul 15; 26(1):107-13. PubMed ID: 7564349
    [Abstract] [Full Text] [Related]

  • 6. Cardiorenal consequences of dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibition in transgenic rats with an extra renin gene.
    Wegner M, Hirth-Dietrich C, Knorr A, Dressel J, Ganten D, Stasch JP.
    Hypertens Res; 1996 Sep 15; 19(3):151-9. PubMed ID: 8891743
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
    Chatelain RE, Ghai RD, Trapani AJ, Odorico LM, Dardik BN, De Lombaert S, Lappe RW, Fink CA.
    J Pharmacol Exp Ther; 1998 Mar 15; 284(3):974-82. PubMed ID: 9495857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
    Seymour AA, Abboa-Offei BE, Smith PL, Mathers PD, Asaad MM, Rogers WL.
    Clin Exp Pharmacol Physiol; 1995 Jan 15; 22(1):63-9. PubMed ID: 7768036
    [Abstract] [Full Text] [Related]

  • 10. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T, Tikkanen I, Rockell MD, Allen TJ, Johnston CI, Cooper ME, Burrell LM.
    Hypertension; 1998 Oct 15; 32(4):778-85. PubMed ID: 9774379
    [Abstract] [Full Text] [Related]

  • 11. Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    Daull P, Benrezzak O, Arsenault D, Pheng LH, Blouin A, Cayer J, Beaudoin M, Belleville K, Sirois P, Nantel F, Jeng AY, Battistini B.
    Am J Hypertens; 2005 Dec 15; 18(12 Pt 1):1606-13. PubMed ID: 16364833
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W, Beslot F, Laboulandine I, Fournié-Zaluski MC, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1996 Aug 15; 278(2):573-81. PubMed ID: 8768706
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of omapatrilat in low, normal, and high renin experimental hypertension.
    Trippodo NC, Robl JA, Asaad MM, Fox M, Panchal BC, Schaeffer TR.
    Am J Hypertens; 1998 Mar 15; 11(3 Pt 1):363-72. PubMed ID: 9544878
    [Abstract] [Full Text] [Related]

  • 15. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
    Farina NK, Johnston CI, Burrell LM.
    J Hypertens; 2000 Jun 15; 18(6):749-55. PubMed ID: 10872560
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.
    J Pharmacol Exp Ther; 1995 Nov 15; 275(2):745-52. PubMed ID: 7473162
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
    Trapani AJ, Beil ME, Bruseo CW, Savage P, Firooznia F, Jeng AY.
    J Cardiovasc Pharmacol; 2004 Nov 15; 44 Suppl 1():S211-5. PubMed ID: 15838282
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.